INGN-234

N/A

Report date: 2022/01/24 17:54:04

Base Information

Drug NameINGN-234
Drug Alias Namep53 topical - Introgen/Colgate-Palmolivep53 gene therapy - Introgen/Colgate-PalmoliveINGN-234
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionP53 gene stimulants
TargetsTumor protein p53
Therapy Area/IndicationsVitiligo
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntrogenColgate-Palmolive CompanyNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntrogenColgate-Palmolive CompanyNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsVitiligo

Other Information

ATC CodeN/A
Related LinksN/A